Universal Display Change in Accounts Receivable 2010-2025 | OLED
Universal Display annual/quarterly change in accounts receivable history and growth rate from 2010 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
- Universal Display change in accounts receivable for the quarter ending June 30, 2025 was $-0.033B, a 315.95% decline year-over-year.
- Universal Display change in accounts receivable for the twelve months ending June 30, 2025 was $0.019B, a 146.48% decline year-over-year.
- Universal Display annual change in accounts receivable for 2024 was $0.026B, a 155.53% decline from 2023.
- Universal Display annual change in accounts receivable for 2023 was $-0.047B, a 415.1% decline from 2022.
- Universal Display annual change in accounts receivable for 2022 was $0.015B, a 159.01% decline from 2021.
Universal Display Annual Change in Accounts Receivable (Millions of US $) |
2024 |
$26 |
2023 |
$-47 |
2022 |
$15 |
2021 |
$-25 |
2020 |
$-22 |
2019 |
$-17 |
2018 |
$9 |
2017 |
$-27 |
2016 |
$1 |
2015 |
$-3 |
2014 |
$-6 |
2013 |
$-7 |
2012 |
$2 |
2011 |
$-3 |
2010 |
$-4 |
2009 |
$-1 |
Sector |
Industry |
Market Cap |
Revenue |
Computer and Technology |
Miscelleneous Electrical Components |
$6.713B |
$0.648B |
Universal Display Corporation is a leading developer of technology and intellectual property (IP) for the Organic Light Emitting Diodes (OLED) market. OLEDs are thin, lightweight and power-efficient solid-state devices that emit light. This can be manufactured on both flexible and rigid substrates, making them highly suitable for use in full-color displays and also as lighting products. The company reports operations mainly under three heads, namely Material sales, Royalty and license fees and Contract research services. Material sales include revenues from both phosphorescent emitter and host materials. Royalty and license fees include fee payments under patent license agreement with SDC, and licensed sales and royalties from customers. Contract research services include revenues earned by Adesis, which performs organic and organometallic synthetics research, development and commercialization on a contractual basis for the company's customers.
|